Lensar (LNSR) Depreciation & Amortization (CF) (2019 - 2026)
Lensar's (LNSR) quarterly Depreciation & Amortization (CF) came in at $904000.0 in Q1 2026, up 7.11% year-on-year from $844000.0 in Q1 2025, and down 4.24% on a QoQ basis from $944000.0 in Q4 2025.
Lensar (LNSR) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $904000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 7.11% year-over-year to $904000.0 in Q1 2026; TTM through Mar 2026 was $3.6 million, a 15.29% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 20.94% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $904000.0, down from $944000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for LNSR reached as high as $944000.0 in Q4 2025 and fell as low as $541000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $713058.8 across 5 years, with a median of $651000.0 in 2023.
- Across the five-year window, Depreciation & Amortization (CF) jumped 66.37% in 2022 and grew 1.93% in 2023, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $577000.0 in 2022, then increased by 12.82% to $651000.0 in 2023, then jumped by 34.25% to $874000.0 in 2024, then advanced by 8.01% to $944000.0 in 2025, then retreated by 4.24% to $904000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $904000.0 in Q1 2026, $944000.0 in Q4 2025, and $928000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | 904,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 904,000.00 |
| Mar 31, 2026 | 904,000.00 |
| Dec 31, 2025 | 944,000.00 |
| Dec 31, 2025 | 944,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Sep 30, 2025 | 928,000.00 |
| Jun 30, 2025 | 865,000.00 |
| Jun 30, 2025 | 865,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Mar 31, 2025 | 844,000.00 |
| Dec 31, 2024 | 874,000.00 |
| Dec 31, 2024 | 874,000.00 |
| Sep 30, 2024 | 774,000.00 |
| Sep 30, 2024 | 774,000.00 |
| Jun 30, 2024 | 666,000.00 |
| Jun 30, 2024 | 666,000.00 |
| Mar 31, 2024 | 647,000.00 |
| Mar 31, 2024 | 647,000.00 |
| Dec 31, 2023 | 651,000.00 |
| Dec 31, 2023 | 651,000.00 |